IN · ai · biotech · diagnostics
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · Nov 2024 · $16M
Celesta Capital lead, Tenacity Ventures, Cedars-Sinai, Eragon, Singularity Ventures
Reported by TechCrunch
Missing a round, or an investor who was in one? Tell us.